Precision Tracking of Samples Enabled at Low Temperatures
|
By LabMedica International staff writers Posted on 28 Feb 2012 |

Image: Each vial is tagged with a unique RFID identifier. The RFID tag is integrated into the vial – it cannot be removed, or fall off inadvertently (Photo courtesy of Biotillion).
A new solution enables real-time (RT) precision tracking of samples in situ at low temperatures.
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
Latest Technology News
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreMolecular Diagnostics
view channel
Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy
Accurate identification of breast cancer patients at risk of relapse after pre-surgery treatment is central to guiding adjuvant decisions, particularly in aggressive disease. Circulating fragments of tumor... Read more
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








